The chronic critically ill patient from the cardiologist's perspective

被引:0
|
作者
Janssens, U. [1 ]
Reith, S. [2 ]
机构
[1] St Antonius Hosp, Innere Med Klin, D-52249 Eschweiler, Germany
[2] Univ Klinikum Aachen, Klin Kardiol Pneumol Angiol & Internist Intens Me, Aachen, Germany
关键词
Heart failure; Ethics; Pacemaker; Ventricular assist device; End of life; HEART-FAILURE-ASSOCIATION; EXPERT CONSENSUS STATEMENT; MECHANICAL CIRCULATORY SUPPORT; IMPLANTABLE ELECTRONIC DEVICES; INTERMACS ANNUAL-REPORT; PATIENTS NEARING END; EUROPEAN-SOCIETY; TASK-FORCE; REQUESTING WITHDRAWAL; POSITION STATEMENT;
D O I
10.1007/s00063-012-0193-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years the prognosis and survival of chronic and acute heart failure (HF) patients has been steadily improving; however, many patients develop advanced chronic HF which is characterized by worsening of symptoms, unplanned hospital admission due to acute decompensation, development of complications, such as life-threatening arrhythmia and shorter life span. Optimal medical therapy is supplemented by interventional cardiology, cardiovascular implantable electronic devices (CIEDs), minimally invasive valve replacement or repair, circulatory mechanical support and heart transplantation. Medical indications and informed consent are essential prerequisites for successfully implementing treatment goals. For patients who are incapable of decisions a legally defined surrogate decision-maker has the same right to refuse or request the withdrawal of treatment as the patient would have if the patient had decision-making capability. As the use of circulatory mechanical support becomes increasingly more prevalent, ethical issues are likely to arise at an increasing rate, as will social and legal ramifications. The concept of turning off an implanted device as death nears is challenging because of ethical and technical concerns. The same holds true for CIEDs. A palliative care approach is applicable to heart failure patients and is particularly relevant to those with advanced disease. Palliative care should be integrated as part of a team approach to comprehensive HF care and should not be reserved for those who are expected to die within days or weeks.
引用
收藏
页码:267 / 278
页数:12
相关论文
共 50 条
  • [41] Mydriasis in a critically ill patient
    Parmar, K. K.
    Dwaram, S.
    Chacko, B.
    ANAESTHESIA AND INTENSIVE CARE, 2009, 37 (05) : 861 - 862
  • [42] NUTRITION IN CRITICALLY ILL PATIENT
    BLACKBURN, GL
    MAINI, BS
    PIERCE, EC
    ANESTHESIOLOGY, 1977, 47 (02) : 181 - 194
  • [43] Sleep in the critically ill patient
    Cooper, AB
    Gabor, JY
    Hanly, PJ
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 22 (02) : 153 - 163
  • [44] Is this critically ill patient immunocompromised?
    Pene, Frederic
    Pickkers, Peter
    Hotchkiss, Richard S.
    INTENSIVE CARE MEDICINE, 2016, 42 (06) : 1051 - 1054
  • [45] Monitoring the critically ill patient
    Gelling, L
    JOURNAL OF ADVANCED NURSING, 2003, 43 (03) : 323 - 323
  • [46] Recognizing the critically ill patient
    Bennett, Kathryn A.
    Robertson, Laura C.
    Al-Haddad, Mohammed
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2016, 17 (01): : 1 - 4
  • [47] Anticoagulation in critically ill patient
    Fries, Dietmar
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2009, 159 (19-20) : 487 - 491
  • [48] The chronically ill patient and the pharmacist. Pharmaceutical care from the patient's perspective
    Beun, JG
    PHARMACY WORLD & SCIENCE, 1996, 18 (06): : 244 - 246
  • [49] Lipids and the critically ill patient
    Calder, PC
    NUTRITION AND CRITICAL CARE, 2003, 8 : 75 - 98
  • [50] MONITORING THE CRITICALLY ILL PATIENT
    HASKINS, SC
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1989, 19 (06) : 1059 - 1078